These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12781177)
1. Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues. El Fangour S; Balas L; Rossi JC; Fedenyuk A; Gretskaya N; Bobrov M; Bezuglov V; Hillard CJ; Durand T Bioorg Med Chem Lett; 2003 Jun; 13(12):1977-80. PubMed ID: 12781177 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. Cano C; Páez JA; Goya P; Serrano A; Pavón J; Rodríguez de Fonseca F; Suardíaz M; Martín MI Eur J Med Chem; 2009 Dec; 44(12):4889-95. PubMed ID: 19762126 [TBL] [Abstract][Full Text] [Related]
3. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors. Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776 [TBL] [Abstract][Full Text] [Related]
4. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957 [TBL] [Abstract][Full Text] [Related]
6. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Haller VL; Stevens DL; Welch SP Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384 [TBL] [Abstract][Full Text] [Related]
8. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864 [TBL] [Abstract][Full Text] [Related]
10. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release. Seillier A; Giuffrida A Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961 [TBL] [Abstract][Full Text] [Related]
11. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552 [TBL] [Abstract][Full Text] [Related]
12. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. Wise LE; Shelton CC; Cravatt BF; Martin BR; Lichtman AH Eur J Pharmacol; 2007 Feb; 557(1):44-8. PubMed ID: 17217945 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin. Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826 [TBL] [Abstract][Full Text] [Related]
14. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. Karanian DA; Brown QB; Makriyannis A; Kosten TA; Bahr BA J Neurosci; 2005 Aug; 25(34):7813-20. PubMed ID: 16120783 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Kim J; Alger BE Nat Neurosci; 2004 Jul; 7(7):697-8. PubMed ID: 15184902 [TBL] [Abstract][Full Text] [Related]
16. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. Palmer JA; Higuera ES; Chang L; Chaplan SR Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380 [TBL] [Abstract][Full Text] [Related]
17. High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. Li C; Xu W; Vadivel SK; Fan P; Makriyannis A J Med Chem; 2005 Oct; 48(20):6423-9. PubMed ID: 16190768 [TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. Lambert DM; Fowler CJ J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824 [No Abstract] [Full Text] [Related]
19. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373 [TBL] [Abstract][Full Text] [Related]
20. Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. Ortar G; Bisogno T; Ligresti A; Morera E; Nalli M; Di Marzo V J Med Chem; 2008 Nov; 51(21):6970-9. PubMed ID: 18831576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]